Inspire Medical Systems (NYSE: INSP) reported Q1 EPS of $0.10, $0.43 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $204.58 million versus the consensus estimate of $200.15 million.

GUIDANCE:

Inspire Medical Systems sees FY2026 EPS of $0.75-$1.25, versus the consensus of $2.03. Inspire Medical Systems sees FY2026 revenue of $825-875 million, versus the consensus of $961.2 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.